CROI 2017
The annual Conference on Retroviruses and Opportunistic Infections (CROI 2017) took place in Seattle, USA from 13-16 February 2017.
-
13-16 February 2017
-
Seattle, US
Integrase inhibitors may increase risk of IRIS in late presenters for HIV treatment
Are people with HIV and HCV co-infection who are cured of hepatitis C with DAAs at increased risk for liver cancer?
Bacterial vaginosis does not affect efficacy of oral PrEP in women
STI rates in PrEP users very high, but evidence that PrEP increases them is inconclusive
Monoclonal antibodies show promise for HIV-positive people with limited treatment options
No evidence of risk compensation after circumcision in three African cohorts
Accelerated linkage to HIV care improves retention in care by a third
Better depression care could improve outcomes for HIV treatment programmes
Peer navigators improve linkage to HIV care and retention in care in South African study
Prednisone reduces the risk of developing TB-IRIS after starting antiretroviral treatment
Will there be a new wave of HIV in people who inject drugs in the US?
New NNRTI doravirine shows good efficacy in phase 3 study
Time spent by people in HIV care in US with a transmissible viral load has fallen by three-quarters since 2000
One in five ‘heterosexual’ men in the UK caught their HIV from another man
When science, community and political will come together, we can end the epidemic, says New York commissioner
Spanish vaccine induces viral control off ART in nearly 40% of recipients
New hepatitis C infections among HIV-positive gay men drop by half after direct-acting antiviral roll-out in Netherlands
Three-drug regimen beats XDR-TB in first trial